Accueil / Tag Archives: Washington (page 46)

Tag Archives: Washington

Adaptive Biotechnologies and Collaborators Present New Data Demonstrating Potential Utility of Next-Generation Sequencing Based Minimal Residual Disease (MRD) Testing as a Surrogate Endpoint for Multiple Myeloma Clinical Trials

Sunday, December 6th 2015 at 12:30pm UTC ORLANDO, Fla.–(BUSINESS WIRE)– Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T-cell and B-cell receptors of the adaptive immune system, and collaborators from the Dana-Farber Cancer Institute and University Hospital in Toulouse, France will today present data …

Plus »

Seattle Genetics Highlights Data from Denintuzumab Mafodotin (SGN-CD19A) Antibody-Drug Conjugate Program at ASH 2015

Sunday, December 6th 2015 at 12:30pm UTC -Updated Data from Phase 1 Clinical Trials Support Further Clinical Evaluation of SGN-CD19A in Randomized Phase 2 Trials: Testing Novel Regimens for Frontline and Relapsed DLBCL- -First Preclinical Data Presented for SGN-CD19B, a Novel Antibody-Drug Conjugate with PBD Dimer Payload; Phase 1 Clinical …

Plus »

Adaptive Biotechnologies Announces Expansion of clonoSEQ® Minimal Residual Disease (MRD) Test

Friday, December 4th 2015 at 2:00pm UTC Patient Cells Harvested for Self-Transplant Can Now Be Assessed SEATTLE–(BUSINESS WIRE)– Adaptive Biotechnologies, the leader in combining next-generation sequencing and expert bioinformatics to profile T-cell and B-cell receptors of the adaptive immune system, today announced that it is expanding the clonoSEQ® Process to …

Plus »

Nohla Therapeutics Launches with Major US Cancer Research Institute Deal, Substantial Investment Round, and Key Appointments

Thursday, December 3rd 2015 at 1:01pm UTC SEATTLE–(BUSINESS WIRE)– Nohla Therapeutics Inc. (Nohla), a new cellular therapies start-up based in Seattle, Washington, is pleased to announce the signing of an exclusive licensing and collaboration agreement with the Fred Hutchinson Cancer Research Center (Fred Hutch). Nohla has also secured an investment …

Plus »

Seattle Genetics to Present at Oppenheimer Healthcare Conference

Wednesday, December 2nd 2015 at 1:00pm UTC BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the 26th Annual Oppenheimer Healthcare Conference on Wednesday, December 9, at 8:35 a.m. Eastern Time. The presentation will be webcast live and available for replay from Seattle Genetics’ website …

Plus »

Seattle Genetics to Webcast Investor and Analyst Event at American Society of Hematology Annual Meeting

Tuesday, December 1st 2015 at 1:00pm UTC BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the company will webcast an investor and analyst event on Monday, December 7, 2015 during the 57th American Society of Hematology (ASH) Annual Meeting in Orlando, FL. Members of Seattle Genetics’ management team …

Plus »

Juno Therapeutics Announces Data Presentations at the American Society of Hematology Annual Meeting

Monday, November 30th 2015 at 9:05pm UTC — Analyst and Investor Event and Webcast on Monday, December 7, at 8:30 p.m. Eastern Time — SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced the Company, …

Plus »

Presage Biosciences Appoints Two New Directors

Tuesday, November 24th 2015 at 12:00pm UTC SEATTLE–(BUSINESS WIRE)– Presage Biosciences, an oncology company pioneering a radical new drug development approach that incorporates human efficacy data much earlier in development and clinical trials, announced today the appointment of Tachi Yamada and Christoph Lengauer to its board of directors. Dr. Yamada, …

Plus »

Patients Rising Honors Cancer Patient Don Wright Preparing to Run His 91st Marathon with Multiple Myeloma

Tuesday, November 24th 2015 at 3:00pm UTC 74-Year Old to Run in the Seattle Marathon November 29th SEATTLE& WASHINGTON–(BUSINESS WIRE)– Patients Rising, a non-profit patient advocacy organization, congratulated 74-year old Don Wright today for his continuing work to raise awareness of blood cancers and for being an advocate for access …

Plus »

Presage Biosciences In-Licenses Clinical Stage Drug Program

Tuesday, November 24th 2015 at 12:00pm UTC SEATTLE–(BUSINESS WIRE)– Presage Biosciences, an oncology company pioneering a radical new drug development approach that incorporates human efficacy data much earlier in development and clinical trials, announced today that it has in-licensed voruciclib, its first clinical stage drug program. Voruciclib is an oral …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.